MedTrace Logo

Opioid Free Anesthesia in Maxillofacial Surgery

NCT05031676 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2021-09-02

No results posted yet for this study

Summary

Opioid free anesthesia is a promising practice in anesthesia. Studies already carried out have compared OFA to an opioid or "opioid anesthesia" (OA) protocol without the use of antihyperalgesic in the OA protocol. Most of the studies currently available have been carried out in Europe, America and a few in Asia under conditions other than those available in precarious situations.That's why we decide to conduct a study to evaluate the effectiveness of an OFA protocol in maxillofacial surgery in Burkina Faso.

Conditions

  • Maxillofacial Surgery

Interventions

OTHER

opioid free anesthesia

Maintenance of anesthesia was done with halothane. The incision was allowed at 1.2 MAC of halothane. This halogen was administered according to the hemodynamic parameters and the habits of the anesthesia team. Before waking up, all the patients benefited from preventive analgesia with 1 g paracetamol combined with 20 mg nefopam by slow intravenous injection over approximately 15 minutes.

Sponsors & Collaborators

  • Université NAZI BONI

    lead OTHER

Principal Investigators

  • Ismael Guibla, Doctor · University Hospital Souro Sanou, Burkina Faso

  • Charles Ilboudo, Doctor · University Hospital Souro Sanou, Burkina Faso

  • Bertille Ki, Professor · Univesity of Joseph KI-ZERBO, Health sciences institute

  • Jean Paul Lechat, Doctor · Hospital of Charleroi (GHdC), Belgium

  • Cheick Bougouma, Doctor · Univesity of Joseph KI-ZERBO, Health sciences institute

  • Alain Traore, Professor · University of Nazi Boni, Health sciences institute

  • Flavien Kabore, Professor · Univesity of Joseph KI-ZERBO, Health sciences institute

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-15
Primary Completion
2020-06-15
Completion
2020-10-05

Countries

  • Burkina Faso

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05031676 on ClinicalTrials.gov